Seminars in Oncology Nursing
Volume 23, Supplement 3 , Pages S11-S14, November 2007

Emerging Agents for the Treatment of Advanced Bladder Cancer

  • Elizabeth Manchen

      Affiliations

    • Corresponding Author InformationAddress correspondence to Elizabeth Manchen, RN, MS, OCN®, Genitourinary Research Nurse Associate, Section of Hematology/Oncology, University of Chicago, 5841 S. Maryland Ave, MC2115, Chicago, IL 60637

Objectives

To review the treatment options for advanced or metastatic bladder cancer, including novel agents.

Data Sources

Research literature and clinical trial data.

Conclusion

Knowledge of current and novel therapies for the treatment of advanced or metastatic bladder cancer is essential in caring for patients in this stage of disease, for whom options are relatively limited.

Implications for Nursing Practice

Oncology nurses can play an important role in assessing patients for appropriate treatments, including enrollment in clinical trials of new agents.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0749-2081(07)00095-2

doi:10.1016/j.soncn.2007.10.008

Seminars in Oncology Nursing
Volume 23, Supplement 3 , Pages S11-S14, November 2007

Article Tools

* Image Usage & Resolution